Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular barriers to direct cardiac reprogramming.

Haley Vaseghi1, Jiandong Liu1, Li Qian2

  • 1Department of Pathology and Laboratory Medicine, McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, 27599, USA.

Protein & Cell
|April 9, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upper gastrointestinal hemorrhage due to splenic artery pseudoaneurysm combined with pancreatic pseudocyst recurrence: A case report.

The Journal of international medical research·2026
Same author

Analysis of Quality Differences in <i>Rhizoma Musae</i> From Different Origins Based on Rhizosphere Soil Bacterial Diversity and Metabolomics.

Food science & nutrition·2026
Same author

Computational interpretation of modified lung ultrasound performance in CTD-ILD.

Clinical rheumatology·2026
Same author

A Continuum of Atrial Peristalsis Initiates the Bicuspid to Quadricuspid Valve Transition.

bioRxiv : the preprint server for biology·2026
Same author

Asymmetric Alkene Boration and <i>Z</i>-Retentive Allylic Substitution Reactions under Cu/Pd Relay Catalysis.

Journal of the American Chemical Society·2026
Same author

Ecological vaccination: A strategy to prevent zoonotic spillover from bats.

Science advances·2026

Direct cardiac reprogramming converts fibroblasts into cardiomyocyte-like cells to repair hearts after myocardial infarction. Optimizing this novel therapy requires overcoming barriers in efficiency, cell identity, and growth factor signaling.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Cardiology

Background:

  • Myocardial infarction (MI) causes significant cardiomyocyte death, leading to reduced heart function and arrhythmias.
  • Current treatments for MI focus on managing symptoms and preventing further damage, but do not fully restore cardiac function.
  • Cardiac scar tissue formation after MI impairs electrical conduction and contractile capacity.

Purpose of the Study:

  • To review the current state of direct cardiac reprogramming for treating myocardial infarction.
  • To identify key factors and barriers influencing reprogramming efficiency and efficacy.
  • To outline future directions for advancing direct cardiac reprogramming towards clinical application.

Main Methods:

  • This review synthesizes findings from studies investigating direct cardiac reprogramming of fibroblasts into induced cardiomyocyte-like cells.
Keywords:
cardiac reprogrammingepigeneticsheart regenerationmyocardial infarction

Related Experiment Videos

  • It examines various reprogramming strategies, including transcription factors, microRNAs, and small molecules.
  • The review analyzes challenges related to reprogramming efficiency, epigenetic modifications, cell fate conversion, and the role of growth factors and environmental cues.

    • Main Results:

    • Direct cardiac reprogramming offers a promising approach to simultaneously reduce scar tissue and generate new cardiomyocytes.
    • Reprogramming efficiency is influenced by the choice of reprogramming factors, their stoichiometry, epigenetic landscapes, and the cellular microenvironment.
    • Incomplete conversion and residual fibroblast identity remain significant hurdles to achieving fully functional cardiomyocyte-like cells.

    Conclusions:

    • Direct cardiac reprogramming holds potential for regenerating heart tissue after myocardial infarction.
    • Further research is needed to optimize reprogramming cocktails, overcome epigenetic barriers, and ensure complete cell fate conversion.
    • Addressing challenges in growth factor signaling and environmental cues is crucial for the clinical translation of this regenerative therapy.